Canine platelet transfusions: State-of-the-Art Review

Journal of Veterinary Emergency and Critical Care

Volumn 19, Issue 5, 2009, Pages 401-415

  Callan, Mary Beth ^a   Appleman, Elizabeth H ^a   Sachais, Bruce S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cryopreservation; Hemostasis; Lyophilization; Plateletpheresis; Thrombocytopenia

Indexed keywords

ANIMAL; ANIMAL DISEASE; BLEEDING; DOG; REVIEW; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS;

ANIMALS; DOGS; HEMORRHAGE; PLATELET TRANSFUSION; PLATELETPHERESIS;

ANIMALIA;

EID: 70350494961     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2009.00454.x     Document Type: Review

References (81)

1. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008 248 : 447 458.
2. Gunter OL, Au BK, Isbell JM, et al. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 2008 65 : 527 534.
3. Vassallo RR, Wahab F, Giordano K, et al. Improving technology for collecting platelets by apheresis: five year experience in one blood center. Transfus Med Rev 2004 18 : 257 266.
4. Vassallo RR, Murphy S. A critical comparison of platelet preparation methods. Curr Opin Hematol 2006 13 : 323 330.
5. Brecher ME. ed. American Association of Blood Banks Technical Manual, 15th ed. Bethesda : AABB 2005.
6. Abrams-Ogg ACG, Kruth SA, Carter RF, et al. Preparation and transfusion of canine platelet concentrates. Am J Vet Res 1993 54 : 635 642.
7. Allyson K, Abrams-Ogg ACG, Johnstone IB. Room temperature storage and cryopreservation of canine platelet concentrates. Am J Vet Res 1997 58 : 1338 1347.
8. Buchholz DH, Squires JE, Herman JH, et al. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator. Transfusion 1997 37 : 715 718.
9. Bolan CD, Greer SE, Cecco SA, et al. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 2001 41 : 1165 1171.
10. Mercan D, Bastin G, Lambermont M, et al. Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis. Transfusion 1997 37 : 418 422.
11. Strauss RG. Mechanisms of adverse effects during hemapheresis. J Clin Apheresis 1996 11 : 160 164.
12. Bolan CD, Cecco SA, Wesley RA, et al. Controlled study of citrate effects and response to IV calcium administration during allogeneic peripheral blood progenitor cell donation. Transfusion 2002 42 : 935 946.
13. Bolan CD, Wesley RA, Yau YY, et al. Randomized placebo-controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms. Transfusion 2003 43 : 1403 1413.
14. Bolan CD, Yau YY, Cullis HC, et al. Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens. Transfusion 2004 44 : 229 238.
15. Haddad S, Leitman SF, Wesley RA, et al. Placebo-controlled study of intravenous magnesium supplementation during large-volume leukapheresis in healthy allogeneic donors. Transfusion 2005 45 : 934 944.
16. Adamik A, Klein A, Mischke R. Technical aspects of extraction of platelet concentrates from dogs with an automated cell separator. Dtsch Tierärztl Wschr 1997 104 : 523 526 (German).
17. Callan MB, Appleman EH, Shofer FS, et al. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs. Transfusion 2008 48 : 2214 2221.
18. Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet viability - deleterious effect of refrigerated storage. N Engl J Med 1969 280 : 1094 1098.
19. Hoffmeister KM, Felbinger TW, Falet H, et al. The clearance mechanism of chilled blood platelets. Cell 2003 112 : 87 97.
20. Hoffmeister KM, Josefsson EC, Isaac NA, et al. Glycosylation restores survival of chilled blood platelets. Science 2003 301 : 1531 1534.
21. Babic AM, Josefsson EC, Bergmeier W, et al. In vitro function and phagocytosis of galactosylated platelet concentrates after long-term refrigeration. Transfusion 2007 47 : 442 451.
22. Wandall HH, Hoffmeister KM, Sørenson AL, et al. Galactosylation does not prevent the rapid clearance of long-term, 4°C-stored platelets. Blood 2008 111 : 3249 3256.
23. Klein A, Adamik A, Mischke R. Changes in platelet concentrates from dogs due to storage. Part I: platelet count and in vitro function of platelets. Beil Münch Tierärztl Wschr 1999 112 : 243 253 (German). (Pubitemid 129638282)
24. Handin RI, Valeri CR. Improved viability of previously frozen platelets. Blood 1972 40 : 509 513.
25. Currie LM, Lichtiger B, Livesey SA, et al. Enhanced circulatory parameters of human platelets cryopreserved with second-messenger effectors: an in vivo study of 16 volunteer platelet donors. Br J Haematol 1999 105 : 826 831.
26. Currie LM, Livesey SA, Harper JR, et al. Cryopreservation of single-donor platelets with a reduced dimethyl sulfoxide concentration by the addition of second-messenger effectors: enhanced retention of in vitro functional activity. Transfusion 1998 38 : 160 167.
27. Valeri CR, Feingold H, Marchionni LD. A simple method for freezing human platelets using 6 percent dimethyl sulfoxide and storage at -80°C. Blood 1974 43 : 131 136.
28. Valeri CR, Feingold H, Melaragno AJ, et al. Cryopreservation of dog platelets with dimethyl sulfoxide: therapeutic effectiveness of cryopreserved platelets in the treatment of thrombocytopenic dogs, and the effect of platelet storage at -80°C. Cryobiology 1986 23 : 387 394.
29. Valeri CR, Ragno G, Khuri S. Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at -80°C without postthaw processing. Transfusion 2005 45 : 1890 1898.
30. Alving BM, Reid TJ, Fratantoni JC, et al. Frozen platelets and platelet substitutes in transfusion medicine. Transfusion 1997 37 : 866 876.
31. Bock M, Schleuning M, Heim MU, et al. Cryopreservation of human platelets with DMSO: changes in biochemistry and cell function. Transfusion 1995 35 : 921 924.
32. Balint B, Paunovic D, Vucetic D, et al. Controlled-rate versus uncontrolled-rate freezing as predictors for platelet cryopreservation efficacy. Transfusion 2006 46 : 230 235.
33. Melaragno AJ, Carciero R, Feingold H, et al. Cryopreservation of human platelets using 6% dimethyl sulfoxide and storage at -80°C. Vox Sang 1985 49 : 245 258.
34. Schiffer CA, Aisner J, Wiernik PH. Frozen autologous platelet transfusion for patients with leukemia. N Engl J Med 1978 299 : 7 12.
35. Guillaumin J, Jandrey KE, Norris JW, et al. Assessment of a dimethyl sulfoxide-stabilized frozen canine platelet concentrate. Am J Vet Res 2008 69 : 1580 1586.
36. Appleman EH, Sachais BS, Patel R, et al. Cryopreservation of canine platelets. J Vet Intern Med 2009 23 : 138 145.
37. Murphy S, Rebulla P, Bertolini F, et al. In vitro assessment of the quality of stored platelet concentrates. Transfus Med Rev 1994 8 : 29 36.
38. Bode AP, Fischer TH. Lyophilized platelets: fifty years in the making. Artif Cells Blood Substit Immobil Biotechnol 2007 35 : 125 133.
39. Read MS, Reddick RL, Bode AP, et al. Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci USA 1995 92 : 397 401.
40. Bode AP, Read MS, Reddick RL. Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber. J Lab Clin Med 1999 133 : 200 211.
41. Bode AP, Lust RM, Read MS, et al. Correction of the bleeding time with lyophilized platelet infusions in dogs on cardiopulmonary bypass. Clin Appl Thromb Hemost 2008 14 : 38 54.
42. Fischer TH, Bode AP, Parker BR, et al. Primary and secondary hemostatic functionalities of rehydrated, lyophilized platelets. Transfusion 2006 46 : 1943 1950.
43. Fischer TH, Merricks EP, Russell KE, et al. Intracellular function in rehydrated lyophilized platelets. Br J Haematol 2000 111 : 167 174.
44. Fischer TH, Merricks EP, Bode AP, et al. Thrombus formation with rehydrated, lyophilized platelets. Hematology 2002 7 : 359 369.
45. Blajchman MA, Lee DH. The thrombocytopenic rabbit bleeding time model to evaluate the in vivo hemostatic efficacy of platelets and platelet substitutes. Transfus Med Rev 1997 11 : 95 105.
46. Bode AP, Read MS. Lyophilized platelets: continued development. Transfus Sci 2000 22 : 99 105.
47. Fischer TH, Merricks E, Bellinger DA, et al. Splenic clearance mechanisms of rehydrated, lyophilized platelets. Artif Cells Blood Substit Immobil Biotechnol 2001 29 : 439 451.
48. 111In-oxine-labelled autologous fresh and lyophilized reconstituted platelets. Vox Sang 2005 88 : 122 129.
49. Wolkers WF, Walker NJ, Tablin F, et al. Human platelets loaded with trehalose survive freeze-drying. Cryobiology 2001 42 : 79 87.
50. Crowe JH, Tablin F, Wolkers WF, et al. Stabilization of membranes in human platelets freeze-dried with trehalose. Chem Phys Lipids 2003 122 : 41 52. (Pubitemid 36207511)
51. Tang M, Wolkers WF, Crowe JH, et al. Freeze-dried rehydrated human blood platelets regulate intracellular pH. Transfusion 2006 46 : 1029 1037.
52. Wolkers WF, Looper SA, McKiernan AE, et al. Membrane and protein properties of freeze-dried mouse platelets. Mol Membr Biol 2002 19 : 201 210.
53. Wolkers WF, Looper SA, Fontanilla RA, et al. Temperature-dependence of fluid phase endocytosis coincides with membrane properties of pig platelets. Biochim Biophys Acta 2003 1612 : 154 163.
54. Tablin F, Walker NJ, Hogle SE, et al. Assessment of platelet growth factors in supernatants from rehydrated freeze-dried equine platelets and their effects on fibroblasts in vitro. Am J Vet Res 2008 69 : 1512 1519.
55. Slichter SJ. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients. J Clin Apheresis 2006 21 : 78 84.
56. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 1997 337 : 1870 1875.
57. Heckman KD, Weiner GJ, Davis CS, et al. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/μL versus 20,000/μL. J Clin Oncol 1997 15 : 1143 1149.
58. 9/L: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998 91 : 3601 3606.
59. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985 66 : 1105 1109.
60. Slichter SJ, Davis K, Enright H, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005 105 : 4106 4114.
61. Davis KB, Slichter SJ, Corash L. Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution. Transfusion 1999 39 : 586 592.
62. Klumpp TR, Herman JH, Gaughan JP, et al. Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion 1999 39 : 674 681.
63. Norol F, Bierling P, Roudot-Thoraval F, et al. Platelet transfusion: a dose-response study. Blood 1998 92 : 1448 1453.
64. National Heart, Lung, and Blood Institute; Transfusion Medicine/Hemostasis Clinical Research Network Optimal platelet dose strategy for management of thrombocytopenia. Available at :. Accessed Oct 23, 2008.
65. Abrams-Ogg ACG. Triggers for prophylactic use of platelet transfusions and optimal platelet dosing in thrombocytopenic dogs and cats. Vet Clin Small Anim 2003 33 : 1401 1418.
66. Valeri CR, Khuri S, Ragno G. Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins. Transfusion 2007 47 : 206S 248S.
67. Valeri CR, Cassidy G, Pivacek LE, et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 2001 41 : 977 983.
68. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent platelet alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997 337 : 1861 1869.
69. Slichter SJ, Fish D, Abrams VK, et al. Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model. Blood 2005 105 : 847 854.
70. Slichter SJ, O'Donnell MR, Weiden PL, et al. Canine platelet alloimmunization: the role of donor selection. Br J Haematol 1986 63 : 713 727.
71. Slichter SJ, Deeg HJ, Kennedy MS. Prevention of platelet alloimmunization in dogs with systemic cyclosporine and by UV-irradiation or cyclosporine-loading of donor platelets. Blood 1987 69 : 414 418.
72. Kickler TS. Principles of platelet transfusion therapy, In : Hoffman R, Benz EJ, Shattil SJ, et al., eds. Hematology: Basic Principles and Practice, 3rd ed. Philadelphia : Churchill Livingstone 2000, pp. 2248 2257.
73. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994 331 : 625 628.
74. Heddle NM, Klama L, Meyer R, et al. A randomized controlled trail comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion 1999 39 : 231 238.
75. Heddle NM, Blajchman MA, Meyer RM, et al. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002 42 : 556 566.
76. Kaufman J, Spinelli SL, Schultz E, et al. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J Thromb Haemost 2007 5 : 788 796.
77. Blumberg N, Gettings KF, Turner C, et al. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006 46 : 1813 1821.
78. Khan SY, Kelher MR, Heal JM, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006 108 : 2455 2462.
79. Schrezenmeier H, Walther-Wenke G, Müller TH, et al. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 2007 47 : 644 652.
80. Eder AF, Kennedy JM, Dy BA, et al. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007 47 : 1134 1142.
81. Jacobs MR, Good CE, Lazarus HM, et al. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008 46 : 1214 1220.